TTR and familial amyloid neuropathy: Two reports were produced during the study period: “Bioabsorbable stents in percutaneous coronary intervention” and “Drugs under development for treating familial amyloid polyneuropathy associated with transthyretin.” These briefs covered two categories of technologies, medical devices and medicines (Figure 1), with the main target audience being health professionals and the academy.